Vyant Bio enters collaboration with Organo Therapeutics to find treatments for Parkinson's Disease
Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts and chief scientific officer Robert Fremeau tells Proactive it has entered into a collaboration agreement with...